Journal ArticleDOI
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
Chloe L. Thio,Eric C. Seaberg,Richard L. Skolasky,John P. Phair,Barbara R. Visscher,Alvaro Muñoz,David L. Thomas +6 more
TLDR
Individuals coinfected with HIV-1 and HBV, especially those with low CD4+ nadir counts, are at increased risk for liver-related mortality, underscoring the importance of prevention, identification, and comprehensive management of hepatitis B in people infected withAIDS.Citations
More filters
Dissertation
A Study on prevalence and characteristics of Hepatitis B or/and Hepatitis C co-infection in patients with HIV in Thanjavur Medical College and Hospital
TL;DR: Raised levels of liver enzymes and lowered mean CD4 counts were seen in HIV-HBV and HIV-HCV co-infections, underscore the importance of screening all HIV positive individuals before initiating antiretroviral treatment.
Journal ArticleDOI
Seroprevalence of hepatitis C virus in Jinan, China, 2008–2020
TL;DR: A comprehensive study on hepatitis C virus (HCV) seroprevalence was conducted among 365,210 patients at Jinan Central Hospital, China, from 2008 to 2020 as discussed by the authors .
Journal ArticleDOI
Suitability of HIV-Infected Subjects for Insurance.
TL;DR: The risk of death, in at least a subset of HIV-positive subjects, is low enough that insurance providers should consider stratifying HIV-infected individuals according to mortality risk and offering insurance rates comparable to people with other diseases with similar mortality risks.
Dissertation
Healthcare Utilization among Persons Living with HIV with Attention to the Influences of Hepatitis Co-Infection and Elite Control
TL;DR: Thesis Committee describes thesis Committee as a “coalition of equals” and the aims of the committee were to “ foster an atmosphere of trust and confidence among the members that is conducive to effective and efficient research.
Journal ArticleDOI
Hepatitis B prophylaxis in HIV-infected patients
TL;DR: The use of double vaccine doses or prolongation of the vaccination schedule is recommended in those whose post-vaccination anti-HBs titers are less than 10 mIU/ml, because the efficacy of immunisation against HBV in this group is much worse than in general population.
References
More filters
Journal Article
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.
N. E. Breslow,N. E. Day +1 more
TL;DR: What do you do to start reading statistical methods in cancer research vol ii the design and analysis of cohort studies?
Journal ArticleDOI
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Miriam J. Alter,Deanna Kruszon-Moran,Omana V. Nainan,Geraldine M. McQuillan,Fengxiang Gao,Linda A. Moyer,Richard A. Kaslow,Harold S. Margolis +7 more
TL;DR: The strongest factors independently associated with HCV infection were illegal drug use and high-risk sexual behavior, and poverty, having had 12 or fewer years of education, and having been divorced or separated were independently associated.
Journal ArticleDOI
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
Yves Benhamou,Marie Bochet,V. Di Martino,Frédéric Charlotte,F. Azria,Anne Coutellier,Michel Vidaud,François Bricaire,Pierre Opolon,Christine Katlama,Thierry Poynard +10 more
TL;DR: In coinfected patients, a low CD4 count, alcohol consumption rate, and age at HCV infection are associated with a higher liver fibrosis progression rate, while HIV seropositivity accelerates HCV‐related liver Fibrosis progression.
Journal ArticleDOI
The multicenter aids cohort study: rationale, organization, and selected characteristics of the participants
TL;DR: The Multicenter AIDS Cohort Study was designed to elucidate the natural history of the infection causing acquired immunodeficiency syndrome (AIDS), identify risk factors for occurrence and clinical expression of the virus, and establish a repository of biologic specimens for future study.
Journal ArticleDOI
Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.
TL;DR: The data indicate that use of ritonavir may increase risk of severe hepatotoxicity, and does not support withholding protease inhibitor therapy from persons coinfected with hepatitis B or C virus.